Respiratory Pathogen Testing Kits Market Size to Hit US$ 3.68 Billion by 2031| Growth Plus Reports

 | Source: Growth Plus Reports Growth Plus Reports

Newark, New Castle, USA, June 23, 2023 (GLOBE NEWSWIRE) -- Growth Plus Reports studied and calculated the global market size for respiratory pathogen testing kits in 2022 to be worth US$ 2.30 billion. It is expected to rise significantly at a sizable revenue CAGR of 5.3% to reach US$ 3.68 billion by 2031.

Analysis of the global market for respiratory pathogen testing kits indicates that during the forecast period, revenue share is likely to increase significantly. Testing kits for respiratory pathogens are diagnostic instruments used to pinpoint specific pathogens, including viruses or bacteria, that can result in respiratory infections.

Key Takeaways: 

  • The increasing number of Covid-19 and other related respiratory disorder cases is driving the market revenue share.
  • The rising demand for pathogen testing kits due to their sensitivity and specificity drives market revenue growth.
  • The demand for early disease detection techniques is increasing the market revenue growth rapidly.

Request a Free Sample PDF: https://www.growthplusreports.com/inquiry/request-sample/respiratory-pathogen-testing-kits-market/8868

                                Respiratory Pathogen Testing Kits Market Scope

Report AttributeDetails
Market Size Value in 2022US$ 2.30 billion
Revenue Forecast in 2031US$ 3.68 billion
CAGR5.3%
Base Year for Estimation2022
Forecast Period2023 to 2031
Historical Year2021
Segments CoveredProduct, Application, End user, and Region
Regional ScopeNorth America, Europe, Asia Pacific, Latin America, and the Middle East & Africa


Recent Development in the Respiratory Pathogen Testing Kits Market: 

  • In September 2022, A novel PCR test, the CLINITEST Rapid COVID-19 + Influenza Antigen Test, and the FTD SARS-CoV-2/FluA/FluB/HRSV Assay have all been made available by Siemens Healthineers.
  • In May 2022, the Multiplex PCR-Fluorescence Probing Six Respiratory Pathogens Diagnostic Kit from Sansure Biotech (GXZZ 20223400597) was given marketing approval. The first domestic test reagent based on multiplex fluorescence PCR technology can detect six common bacteria in a single tube; it is a ground-breaking tool for molecular diagnosis. 

Competitive Landscape

A list of key players operating in the global market for respiratory pathogen testing kits includes: 

  • Danaher Corporation
  • Altona Diagnostics
  • Siemens Healthineers AG
  • Abbott Laboratories Inc.
  • Thermo Fisher Scientific Inc.
  • F. Hoffmann-La Roche AG

Market Drivers and Restraints: 

The global respiratory pathogen testing kits market revenue is driven as respiratory diseases are becoming more common, there is a greater need for quick and precise diagnostic tests, people are becoming more aware of the value of early detection, and cutting-edge technologies are available.

However, due to the lack of awareness, and limited availability of healthcare infrastructure, the respiratory pathogen testing kits market revenue growth is expected to be restrained. 

Market Segmentation: 

  • Based on products, the respiratory pathogen testing kits market is segmented into ELISA kits, RT PCR kits, lateral flow test kits, and others.
  • Based on application, the respiratory pathogen testing kits market is segmented into respiratory syncytial virus infection, influenza virus infection, and others.
  • Based on end users, the respiratory pathogen testing kits market is segmented into hospitals, diagnostic centers, and others.

Segmentation By Products

Based on the products, the lateral flow test kits segment dominates the global respiratory pathogen testing kits market with the largest revenue share. This large revenue share is attributed to the increase in testing for the diagnosis of chronic disease. 

Request for Customization – https://www.growthplusreports.com/inquiry/customization/respiratory-pathogen-testing-kits-market/8868

Regional Growth Dynamics

Based on the region, North America, with the largest revenue share, dominates the global respiratory pathogen testing kits market. This large revenue share is due to respiratory infections becoming more common; therefore, precise, and quick diagnostic tests are needed. 

Report Coverage 

Growth Plus Reports conducted extensive research on the world market for respiratory pathogen testing kits. We looked at the basic market traits, important investment spheres, regional growth analytics, revenue projections, rival market participants, and mergers and acquisitions.

Table of Content

  1. INTRODUCTION
    1. Market Ecosystem
    2. Timeline Under Consideration
      1. Historical Years – 2021
      2. Base Year – 2022
      3. Forecast Years – 2023 to 2031
    3. Currency Used in the Report
  2. RESEARCH METHODOLOGY 
    1. Research Approach
    2. Data Collection Methodology
    3. Data Sources
      1. Secondary Sources 
      2. Primary Sources 
    4. Market Estimation Approach
      1. Bottom Up
      2. Top Down 
    5. Market Forecasting Model
    6. Limitations and Assumptions
  3. PREMIUM INSIGHTS
    1. Current Market Trends (COVID-19 Perspective)
    2. Key Players & Competitive Positioning (2022)
    3. Regulatory Landscape
  4. MARKET DYNAMICS
    1. Drivers
    2. Restraints/Challenges
    3. Opportunities
  5. GLOBAL RESPIRATORY PATHOLOGY TESTING KITS MARKET - ANALYSIS & FORECAST, BY PRODUCT
    1. ELISA Kits
    2. RT PCR Kits
    3. Lateral Flow Test Kits
    4. Others
  6. GLOBAL RESPIRATORY PATHOLOGY TESTING KITS MARKET - ANALYSIS & FORECAST, BY APPLICATION
    1. Respiratory Syncytial Virus Infection
    2. Influenza Virus Infection
    3. Others
  7. GLOBAL RESPIRATORY PATHOLOGY TESTING KITS MARKET - ANALYSIS & FORECAST, BY END USER
    1. Hospitals
    2. Diagnostic Centers
    3. Others

RESPIRATORY PATHOLOGY TESTING KITS MARKET TOC

Buy this Premium Research Report: https://www.growthplusreports.com/checkout-8868

 VALUE PROPOSITIONS RELATED TO THE REPORT:

  • Powered with Complimentary Analyst Hours and Expert Interviews with Each Report
  • Comprehensive quantitative and qualitative insights at segment and sub-segment level
  • Covid 19 impact trends and perspective
  • Granular insights at global/regional/country level
  • Deep-rooted insights on market dynamics (drivers, restraints, opportunities) and business environment
  • Blanket coverage on competitive landscape
  • Winning imperatives
  • Exhaustive coverage on 'Strategic Developments' registered by leading players of the market.

CUSTOMIZATION OPTIONS:

  • Distributor Landscape Assessment
  • Pricing Intelligence
  • Customer Base Assessment
  • Investment & Initiatives Analysis
  • 'Business Profile' of Key Players

Schedule a call with our analyst: https://appoint.ly/s/salesZ3Jvd3RocGx1c3JlcG9ydHMuY29t/introduction

Visit our report store at - https://www.growthplusreports.com/report-store

Browse more latest healthcare reports:

Orthopedic Biomaterials Market by Material Type (Polymers, Ceramics & Bioactive Glasses, Calcium Phosphate Cement), Application (Joint Replacement/Reconstruction, Orthobiologics, Viscosupplementation)-Global Outlook & Forecast 2023-2031

Specialty Generics Market by Route of Administration (Injectables, Oral drugs, Others), Indication (Oncology, Inflammatory Conditions, Multiple Sclerosis) End-Use: Specialty Pharmacy, Retail Pharmacy, Hospital Pharmacy) – Global Outlook & Forecast 2023-2031

Gastric Motility Disorder Drugs Market by Drug Class (Cholinergic Agonists, Prokinetic Agents), Route of Administration (Oral, Subcutaneous, Intramuscular), Distribution Channel (Hospital Pharmacies, Retail Pharmacies) – Global Outlook & Forecast 2023-2031

Nephrology Drugs Market by Drug Class (ACE Inhibitors, Beta Blockers), Route of Administration (Oral, Parenteral), Distribution Channel (Hospital Pharmacies, Retail Pharmacies)– Global Outlook & Forecast 2023-2031

Diabetes Drugs Market by Drugs (Oral Anti-Diabetic Drugs, Insulin), Type (Type 1, Type 2), Distribution Channel (Hospital Pharmacies, Retail Pharmacies)– Global Outlook & Forecast 2023-2031

About Us:

Growth Plus Reports is part of GRG Health, a global healthcare knowledge service company. We are proud members of EPhMRA (European Pharmaceutical Marketing Research Association).

Growth Plus portfolio of services draws on our core capabilities of secondary & primary research, market modelling & forecasting, benchmarking, analysis and strategy formulation to help clients create scalable, ground-breaking solutions that prepare them for future growth and success.

We were awarded by the prestigious CEO Magazine as "Most Innovative Healthcare Market Research Company in 2020".

 

            








        

            

                

                    
Tags

                            
                                Respiratory Pathogen Testing
                            

                



        


    

        
Related Links

        
    



    

        

        
Contact Data